
iHisto
About CRO
About CRO
iHisto, a global digital pathology CRO headquartered in Boston, MA, provides advanced histopathology and image analysis solutions to accelerate preclinical and clinical research. Using AI-powered tools and high-resolution whole-slide imaging, iHisto enables precise tissue evaluation and biomarker quantification across oncology, immunology, and toxicology studies.
Why Choose iHisto?
Digital Pathology Expertise: We combine state-of-the-art slide scanning with AI-driven image analytics for rapid, reproducible results.
Comprehensive Services: From tissue processing and staining to quantitative pathology and report generation, we deliver full-service histopathology support.
Fast Turnaround: Standard projects completed in 1–2 weeks with real-time status updates through the iHisto portal.
Collaborative Research Model: We work closely with biotech, pharma, and academic partners to design customized pathology workflows.
Scalable & Secure: Cloud-based data management and scalable infrastructure for studies of any size, ensuring compliance with GLP and FDA standards.




